Literature DB >> 18698329

The promise of human induced pluripotent stem cells for research and therapy.

Shin-ichi Nishikawa1, Robert A Goldstein, Concepcion R Nierras.   

Abstract

Induced pluripotent stem (iPS) cells are human somatic cells that have been reprogrammed to a pluripotent state. There are several hurdles to be overcome before iPS cells can be considered as a potential patient-specific cell therapy, and it will be crucial to characterize the developmental potential of human iPS cell lines. As a research tool, iPS-cell technology provides opportunities to study normal development and to understand reprogramming. iPS cells can have an immediate impact as models for human diseases, including cancer

Entities:  

Mesh:

Year:  2008        PMID: 18698329     DOI: 10.1038/nrm2466

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  155 in total

Review 1.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

2.  Induced Pluripotent Stem Cells-A New Foundation in Medicine.

Authors:  George T-J Huang
Journal:  J Exp Clin Med       Date:  2010-10-22

3.  Stem cells: holding on to the memories.

Authors:  Kim Baumann
Journal:  Nat Rev Mol Cell Biol       Date:  2010-08-18       Impact factor: 94.444

4.  The potential landscape of genetic circuits imposes the arrow of time in stem cell differentiation.

Authors:  Jin Wang; Li Xu; Erkang Wang; Sui Huang
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

Review 5.  Immunogenicity and allogenicity: a challenge of stem cell therapy.

Authors:  Dominique Charron; Caroline Suberbielle-Boissel; Reem Al-Daccak
Journal:  J Cardiovasc Transl Res       Date:  2008-09-26       Impact factor: 4.132

Review 6.  The challenge of immunogenicity in the quest for induced pluripotency.

Authors:  Paul J Fairchild
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

7.  Liver regeneration from induced pluripotent stem cells.

Authors:  Xin Cheng; Paul Gadue
Journal:  Mol Ther       Date:  2010-12       Impact factor: 11.454

8.  Achieving pluripotency.

Authors:  Kim Baumann
Journal:  Nat Rev Mol Cell Biol       Date:  2010-10       Impact factor: 94.444

9.  Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation.

Authors:  Guiying Wang; Xudong Guo; Wujun Hong; Qidong Liu; Tingyi Wei; Chenqi Lu; Longfei Gao; Dan Ye; Yi Zhou; Jie Chen; Jianmin Wang; Minjuan Wu; Houqi Liu; Jiuhong Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

10.  The noncoding RNA IPW regulates the imprinted DLK1-DIO3 locus in an induced pluripotent stem cell model of Prader-Willi syndrome.

Authors:  Yonatan Stelzer; Ido Sagi; Ofra Yanuka; Rachel Eiges; Nissim Benvenisty
Journal:  Nat Genet       Date:  2014-05-11       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.